tbuckley/cabot-search huggingface dataset:
Sociodemographic Determinants of Allogeneic Hematopoietic Stem Cell Transplant Outcomes
Authors: Matthew McGuirk, Moazzam Shahzad, Sohaib Irfan, Muhammad Kashif Amin, Sibgha Gull Chaudhary, Iqra Anwar, Shaun DeJarnette, Forat Lutfi, Al-Ola Abdallah, Anurag K. Singh, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Moazzam Shahzad, Sohaib Irfan, Muhammad Atif Khan, Muhammad Kashif Amin, Matthew McGuirk, Sibgha Gull Chaudhary, Faiza Humayun Khan, Iqra Anwar, Peiman Hematti, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
A Balancing Act: Outcomes of Post-Transplant Cyclophosphamide in Older Patients
Authors: Herman Van Besien, Samuel Yamshon, Alexandra Gomez-Arteaga, Nora Chokr, Sebastian A. Mayer, Michelle S Pasciolla, Rachel Abramova, Tsiporah B. Shore, Juliet N Barker, Anna Alperovich
Journal: Blood (2024)
SYNCRIP promotes cell cycle progression and lung tumorigenesis by modulating <i>AURKB</i> translation
Authors: Hyeon Ji Kim, Hye Guk Ryu, Mingyu Kang, Namgyu Lee, Hyo‐Jin Kim, Dahye Lee, Chaeuk Chung, Sangjune Kim, Kyung‐Ha Lee, Wanil Kim, Jin‐Seok Byun, Kyong‐Tai Kim, Do‐Yeon Kim
Journal: Cancer Communications (2024)
3D Biofabrication of Microporous Hydrogels for Tissue Engineering
Authors: Ziyang Liu, Jialin Wu, Zeyu Luo, Yingying Hou, Leyan Xuan, Changyi Xiao, Jishuo Chang, Dongyang Zhang, Guodong Zheng, Jie Guo, Guosheng Tang, Xiyong Yu
Journal: Advanced Healthcare Materials (2024)

Abstract Microporous hydrogels have been utilized in an unprecedented manner in the last few decades, combining materials science, biology, and medicine. Their microporous structure makes them suitable for wide applications, especially as cell carriers in tissue engineering and regenerative medicine. Microporous hydrogel scaffolds provide spatial and platform support for cell growth and proliferation, which can promote cell growth, migration, and differentiation, influencing tissue repair and regeneration. This review gives an overview of recent developments in the fabrication techniques and applications of microporous hydrogels. The fabrication of microporous hydrogels can be classified into two distinct categories: fabrication of non‐injectable microporous hydrogels including freeze‐drying microporous method, two‐phase sacrificial strategy, 3D biofabrication technology, etc., and fabrication of injectable microporous hydrogels mainly including microgel assembly. Then, the biomedical applications of microporous hydrogels in cell carriers for tissue engineering, including but not limited to bone regeneration, nerve regeneration, vascular regeneration, and muscle regeneration are emphasized. Additionally, the ongoing and foreseeable applications and current limitations of microporous hydrogels in biomedical engineering are illustrated. Through stimulating innovative ideas, the present review paves new avenues for expanding the application of microporous hydrogels in tissue engineering.
Antiviral immunity lassoed down by excess RNA
Authors: Erika Valeri, Anna Kajaste-Rudnitski
Journal: The Journal of Experimental Medicine (2024)

Two complementary works by Chan et al. (https://doi.org/10.1084/jem.20231725), and Ru et al. (https://doi.org/10.1084/jem.20240010), identify defective RNA processing as the root cause of impaired antiviral immunity against SARS-CoV2 in the human brainstem. These studies provide molecular insight into virus-associated severe brainstem encephalitis through PKR inactivation.
Optimized Multi-Class <i>VTE-BERT</i> Large Language Model for Prediction of Cancer Associated Thrombosis Phenotype
Authors: Ang Li, Omid Jafari, Shengling Ma, Arash Maghsoudi, Barbara D Lam, Justine Ryu, Jun Yang Jiang, Mrinal Ranjan, Emily Zhou, Raka Bandyo, Bo Peng, Christopher I Amos, Nathanael R. Fillmore, Abiodun O. Oluyomi, Jennifer La
Journal: Blood (2024)
Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial
Authors: Meagan Jacoby, David H Spencer, Geoffrey L. Uy, Feng Gao, Tasha Burton, Sharon E Heath, Feiyu Du, Shelly O'Laughlin, Robert Fulton, Zeina A. Al-Mansour, Christopher R. Cogle, Eric J Huselton, John F. DiPersio, Peter Westervelt, Mark A. Schroeder, Armin Ghobadi, Iskra Pusic, Keith Stockerl-Goldstein, Brad S. Kahl, Amanda F. Cashen, Matt Christopher, Nathan Singh, Ravi Vij, Zachary D. Crees, Ryan B. Day, Todd A Fehniger, Karolyn Oetjen, Dilan A. Patel, Miriam Y Kim, Michael Slade, Daniel C. Link, Matthew J. Walter, Camille N. Abboud, Ramzi Abboud, Timothy J Ley
Journal: Blood (2024)
Travel Time from Cancer Center Is Associated with Disparities in Non-Hodgkin Lymphoma Diagnosis Among People Living with HIV in Malawi
Authors: Meagan Harrington, Amon Chirwa, Edwards Kasonkanji, Lusayo Simwinga, Noel Mumba, Maria Chikasema, Phaleda Kumwenda, Matthew S Painschab, Yuri D. Fedoriw
Journal: Blood (2024)
Venetoclax and Decitabine Compared with Standard Intensive Chemotherapy As Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia: Updated Results of a Multicenter, Randomized, Phase 2b Trial
Authors: Jing Lu, Shengli Xue, Ying Wang, Xuefeng He, Xiaohui Hu, Miao Miao, Yang Zhang, Zaixiang Tang, Jundan Xie, Xiaofei Yang, Mingzhu Xu, Yaoyao Shen, Feng Du, Qian Vicky Wu, Mengxing Xue, Yun Wang, Ailing Deng, Xueqing Dou, Haiping Dai, Depei Wu, Suning Chen
Journal: Blood (2024)
CD38 Overexpressed Monocytes Play a Critical Role in the Fibrogenesis in Myeloproliferative Neoplasms and Can be Used As a Therapeutic Target to Ameliorate Fibrosis
Authors: Yiru Yan, Jinqin Liu, Lin Yang, Gang Huang, Xiaofan Zhu, Raajit Rampal, Zhijian Xiao, Bing Li
Journal: Blood (2024)
Evaluation of AZD0486, a Novel CD19xCD3 T-Cell Engager, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in an Ongoing First-in-Human Phase 1 Study: High Complete Responses Seen in CAR-T-Naive and CAR-T-Exposed Patients
Authors: Sameh Gaballa, Jing-Zhou Hou, Sumana Devata, Seok-Goo Cho, Ranjit Nair, Dok Hyun Yoon, Ryan Jacobs, Koji Izutsu, Don A. Stevens, Dai Maruyama, Constantine S. Tam, Yazeed Sawalha, Aravind Ramakrishnan, Matthew Matasar, Denise Brennan, Sue Zhu, Robin Lesley, Yasuhiro Oki, David Sermer, Tae Min Kim
Journal: Blood (2024)
Treatment-Related Neuropathy Following Brentuximab-Vedotin in African Americans Treated for Lymphoma: A Retrospective Chart Review
Authors: Carlos Alberto Lopez, Tyler Franklin Simonek, Mosope Folashade Balogun, Kimberly Janelle Noriega, Samuel Ogunbode, Khadijah Shade Olowu, Cristian Ramirez Rodriguez, Angelo Thomas Marra, Leon Bernal-Mizrachi
Journal: Blood (2024)
Clinical Outcome and Molecular Profile in Patients with <i>DDX41</i> Mutation Hotspots: A Retrospective Study of 82 Patients
Authors: Nadia Toumeh, Yazan Jabban, Ahmad Nanaa, Rong He, David Viswanatha, Dragan Jevremovic, James M. Foran, Cecilia Y. Arana Yi, Antoine N. Saliba, Mehrdad Hefazi, William J. Hogan, Mithun V Shah, Abhishek A. Mangaonkar, Mrinal M. Patnaik, Hassan B Alkhateeb, Aref Al-Kali
Journal: Blood (2024)
Mutation-Specific Differences in the Relationship between Obesity and Clonal Hematopoiesis, with a Focus on <i>JAK2V617F</i> and MPN Prevention
Authors: Benjamin Rolles, Aswin Sekar, Laura Serrano-Ron, Noorul Mifra Ameerul Faiz, Andrea Perry, Addison Clare Hillerbrandt, Jessica Hem, Jonas Jutzi, Anna E. Marneth, Abhishek Niroula, Alexander G. Bick, Christopher J. Gibson, Gabriel K. Griffin, Md Mesbah Uddin, Pradeep Natarajan, Benjamin Levine Ebert, Peter van Galen, Fatima Al-Shahrour, Sahand Hormoz, Ann Mullally
Journal: Blood (2024)
Factors Associated with Progression to Overt Acute Myeloid Leukemia in <i>NPM1</i>-Mutated Myeloid Neoplasms with Less Than 10% Blasts
Authors: Jingye Gong, Tiejun Qin, Zefeng Xu, Bing Li, Shiqiang Qu, Lijuan Pan, Qingyan Gao, Meng Jiao, Robert Peter Gale, Zhijian Xiao
Journal: Blood (2024)
Underweight Body Mass Index Is an Independent Risk Factor for Overall Survival in Diffuse Large B-Cell Lymphoma Treated with Rituximab, Prednisolone, Cyclophosphamide, Vincristine, and Doxorubicin: A Lymphoma and Related Diseases Registry Study
Authors: Yao Yao, Serif Sungur, Cameron Wellard, Eliza Chung, Susan Morgan, Denise Lee, Geoffrey Chong, Chan Y. Cheah, Eliza A. Hawkes, Erica M. Wood, Nada Hamad, Anna M. Johnston, Tasman Armytage
Journal: Blood (2024)
ICT01, an Investigational γ9δ2 T Cell Activator, Added to Azacitidine-Venetoclax Achieves Frequent and Early Complete Remissions in Adults with AML Unfit for Intensive Induction Chemotherapy: Interim Results from the Ongoing Open-Label, Randomized Phase 1 Study Eviction
Authors: Abhishek Maiti, Pierre Yves Dumas, Pierre Peterlin, Daniel Morillo, Jose Torregrosa, Paul B. Koller, Maelle Mairesse, Patrick Brune, Emmanuel Valenitn, Aude De Gassart, Katrien Lemmens, Daniel Olive, Naval Daver, Stephan Braun, Sylvain Garciaz
Journal: Blood (2024)
Mapping the Human Bone Marrow in Myeloproliferative Neoplasia Using Spatial Transcriptomics
Authors: Rosalin Cooper, Emily Thomas, Dawood Muhammad, Carlo Pescia, Anna Sozanska, Oliver McCallion, Hosuk Ryou, Renuka Teague, Alan King Lun Liu, Joanna Hester, Fadi Issa, Bethan Psaila, Adam J Mead, Jens Rittscher, Dan Woodcock, Daniel Royston
Journal: Blood (2024)
Treosulfan Vs Busulfan As Part of Clofarabine Based Reduced Intensity Conditioning Regimen before Allotransplant for Myeloid Malignancies
Authors: Laura Prin Felix, Maxime Jullien, Amandine Le Bourgeois, Alice Garnier, Pierre Peterlin, Sophie Vantyghem, Aude-Marie Fourmont, Thierry Guillaume, Patrice Chevallier
Journal: Blood (2024)
High-Dose Cytarabine with Idarubicin Versus High-Dose Cytarabine within First Consolidation for Acute Myeloid Leukemia in First Complete Remission: An Open-Label, Multicenter, Randomized, Phase 3 Trial
Authors: Zinan Feng, Yu Zhang, Hui Liu, Sijian Yu, Qifa Liu, Li Xuan
Journal: Blood (2024)
Characteristics, Treatment Patterns, and Outcomes of Patients with Multiple Myeloma Retreated with Daratumumab in Real-World Clinical Practice in the USA
Authors: Sikander Ailawadhi, Sarah M. Larson, Shannon Ferrante, Nicole Rafalko, Niodita Gupta-Werner, Jennifer S. Harper, Rohan Medhekar, Marjohn Armoon, Annelore Cortoos, Shuchita Kaila, Shebli Atrash
Journal: Blood (2024)
Overexpression of GAD1 in Pediatric Acute Myeloid Leukemia Cells Impairs Cytotoxic T Lymphocyte Response to Tumor Cells
Authors: Xiaoxiao Chen, Bowen Cui, Shuang Zhao, Kefei Wu, Yangyang Xie, Hui Liu, Jiaoyang Cai, Xiang Wang, Yixiao Mo, Wenting Hu, Changcheng Chen, Han Wang, Ronghua Wang, Huiying Sun, Jianan Rao, Wenyan Wu, Yu Liu, Shuhong Shen
Journal: Blood (2024)
AML Stem Cell Clearance By Inhibiting Selenoprotein Biosynthesis That Causes Cgas-Sting Activation and Ferroptosis
Authors: Lingli He, Ting Zhao, Wei Zhong Leong, Azeem Sharda, Christina Mayerhofer, Shenglin Mei, Gracia M. Bonilla, Juan Bautista Menendez-Gonzalez, Karin Gustafsson, Tsuyoshi Fukushima, Trine A. Kristiansen, Ji-Won Lee, Yanxin Xu, Bogdan Budnik, Ruslan Sadreyev, Zhixun Dou, David B. Sykes, David Scadden
Journal: Blood (2024)
Effectiveness and Safety for Re-Treatment with Brentuximab-Vedotin in Patients with Relapsed/Refractory (R/R) CD30+ Malignancies: A Retrospective Medical Chart Review Study in Spain. the Believe Study. NCT:04998331
Authors: Ramon Garcia-Sanz, Anna Sureda Balari, Eva Domingo Domenech, Francisco Javier Capote Huelva, Antonio Gutierrez, Antonia Rodriguez Izquierdo, Marta Grande De Domingo, Lourdes Baeza
Journal: Blood (2024)
A Medical Chart Review of Healthcare Costs in Patients with Systemic Amyloid Light Chain Amyloidosis By Mayo 2012 Stage in the United States
Authors: Morie A. Gertz, Heather J. Landau, Vaishali Sanchorawala, Manisha Bhutani, Jeffrey A. Zonder, Michael Rosenzweig, Gray Magee, Cynthia Campos, Irina Yermilov, Eunice Chang, Michael S. Broder, Preeti Bajaj
Journal: Blood (2024)
Real World Data of Novel Talicabtagene Autoleucel (humanized CD19 CAR-T) from India; Ensuring Equitable Access with Excellent Safety and Efficacy Profile
Authors: Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Manivasagam S, Anand Vaibhaw, Ashish Saroha, Ankesh K. Jaiswal, Alok Shetty, Lingaraj Nayak, Bhausaheb Bagal, Neeraj Siddharthan, Esha Kaul, Prashant Mehta, Anshul Gupta, Navin Khattry, Nishant Jindal, Sanket P Shah, Rakesh Kumar Boya, Pavan Kumar Boyella, Preeti Desai, Anisha Navkudkar, Shalini Purwar, Manju Sengar, Nirali N. Shah, Sattva S. Neelapu, Rahul Purwar
Journal: Blood (2024)
Statins Kill Acute Myeloid Leukemia Cells through Low-Density Lipoprotein Receptor-Mediated Unfolded Protein Response Activation
Authors: Yohei Yasuda, Yuta Fukui, Ken Morita, Muzhapaer Mubalizi, Hiroki Hayashida, Toshiya Hino, Yosuke Masamoto, Mineo Kurokawa
Journal: Blood (2024)
A Polish Adult Leukemia Group (PALG) Prospective International Randomized Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) in Acute Myeloid Leukemia (AML) Patients ≤ 60 Years Old (PALG-AML1/2016) - Topline Results
Authors: Agnieszka Wierzbowska, Agnieszka Pluta, Anna Czyz, Marta Libura, Sebastian Giebel, Michał Soin, Damian Mikulski, Kacper Kościelny, Wojciech Fendler, Magdalena Czemerska, Agata Majchrzak, Anna Kopinska, Krzysztof Woźniczka, Martyna Włodarczyk, Karol Wójcik, Grzegorz Helbig, Małgorzata Raźny, Marta Sobas, Tomasz Wróbel, Donata Szymczak, Andrzej Szczepaniak, Lidia Gil, Magdalena Dutka, Maria Bieniaszewska, Tomasz Gromek, Marek Hus, Edyta Cichocka, Janusz Hałka, Elzbieta Patkowska, Marzena Wątek, Jolanta Wozniak, Ewa Lech-Maranda, Agata Obara, Agnieszka Kopacz, Katarzyna Dulik, Grzegorz Charlinski, Jerzy Holowiecki, Andi Rustani, Ameenah Sukkur, Nuria Mencia-Trinchant, Pinkal Desai, Michael Samuel, Justin D. Kaner, Michal Bar-Natan, Jonathan Canaani, Ellen K. Ritchie, Monica L Guzman, Sylvie D Freeman, Gail J. Roboz
Journal: Blood (2024)
An Interleukin 27 Dependent Lysosomal Thiol Reductase Regulates Regulatory T Cell Survival and Mitochondrial Fitness during Graft Versus Host Disease
Authors: Jonathan Florentin, Alison Moe, Ravi K Shah, Jacek Zielonka, Mark Castleberry, Alex Myers, Marlenny Vargas-Cortes, Jessica L Schmeling, Anthony E Zamora, William R Drobyski
Journal: Blood (2024)
Ultra Long-Term Myeloma Survivors (&amp;gt;15 years): Characteristics of a Unique Group of Myeloma Patients
Authors: Meletios-Athanasios Dimopoulos, Despina Fotiou, Foteini Theodorakakou, Irene Solia, Vasiliki Spiliopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Erasmia Psimenou, Nikolaos Kanellias, Maria Roussou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis
Journal: Blood (2024)
Comparative Real-World Outcomes of Commercial CD19-Directed CAR T-Cell Therapies in Large B-Cell Lymphoma
Authors: Xavier Deschênes-Simard, Maria Bromberg, Sean M. Devlin, Ofrat Beyar Katz, Andrew Ip, Ronit Marcus, Abraham Avigdor, Annamaria Ballweg, Emma Rabinovich, Mohammad Alhomoud, Alfredo Rivas-Delgado, Magdalena Corona, Alejandro Luna De Abia, Maria Lia Palomba, Gunjan L. Shah, Richard J. Lin, Alexander P. Boardman, Lorenzo Falchi, Jennifer Kimberly Lue, Gilles Salles, Miguel-Angel Perales, Roni Shouval, Parastoo B Dahi, Michael Scordo
Journal: Blood (2024)
Clinical Implications of Treatment-Related Clonal Hematopoiesis in Adolescent and Young Adult Survivors of Acute Lymphoblastic Leukemia
Authors: Habib El-Khoury, Ella Postich, Diren Arda Karaoglu, Aishwarya Atmakuri, Hamed Rahmani Youshalouei, Syed Shah, Wendy Stock, Tara O. Henderson, Adam Duvall, Caner Saygin
Journal: Blood (2024)
Real World Evidence of Efficacy of CPX-351 in Secondary Acute Myeloid Leukemia Defined According to Who 2022 Classification
Authors: Carola Riva, Paola Minetto, Maria Chies, Chiara Vernarecci, Giada Zecchetti, Elena Maio, Ylenia Azzanelli, Nicoletta Colombo, Sara Rosellini, Alessia Parodi, Elisabetta Tedone, Enrico Carminati, Francesco Puglisi, Clara Nurra, Giuseppina Fugazza, Paolo Nozza, Michele Cea, Roberto Massimo Lemoli, Fabio Guolo
Journal: Blood (2024)
MBS314, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x B-Cell Maturation Antigen (BCMA) x CD3 Trispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM): Preliminary Results from a Phase Ⅰ, First-in-Human, Open-Label, Dose Escalation Study
Authors: Gang An, Lijie Xing, Wenming Chen, Yan Zhang, Wen Gao, Lu-Gui Qiu, Guojin Wu, Jinying Ning, Min Wei, Feng Li
Journal: Blood (2024)
Protein Degrader WH25244 Eliminates Venetoclax Resistance Factors: Mutant or Hyperphosphorylated BCL2, and BCL-XL
Authors: Daisy Y. Diaz Rohena, Andrew D. Mitchell, Jing Wang, Stephanie Chamberlain, Chaomei Liu, John R. Sanchez, Charmelle D. Williams, Trisha K. Wathan, Bailey Slawin, Kevin Bowman, Yaxia Yuan, Peiyi Zhang, Wanyi Hu, Guangrong Zheng, William G. Wierda, Nitin Jain, Matthew S. Davids, Daohong Zhou, Jennifer A. Woyach, Deepa Sampath
Journal: Blood (2024)
Immune Checkpoint Inhibitors in Primary Mediastinal B-Cell Lymphoma: A Monocentric Real-Life Experience and Future Potential
Authors: Pier Luigi Zinzani, Lisa Argnani, Martina Cantelli, Gabriele Gugliotta, Beatrice Casadei, Marianna Gentilini, Vittorio Stefoni, Cinzia Pellegrini, Alice Morigi, Nicole Fabbri, Giulia Gabrielli, Camilla Mazzoni, Pierluca Maglio, Gianmarco Bagnato, Alessandro Broccoli
Journal: Blood (2024)
Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia with t(16;21)(p11;q22)
Authors: Satoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, Masamitsu Yanada, Shohei Mizuno, Naoyuki Uchida, Noriko Doki, Ayumu Ito, Masatsugu Tanaka, Tetsuya Nishida, Yuta Katayama, Satoshi Yoshihara, Tetsuya Eto, Koji Kawamura, Makoto Onizuka, Takahiro Fukuda, Marie Ohbiki, Yoshiko Atsuta, Takaaki Konuma
Journal: Blood (2024)
CAR T-Cells Treatment for Relapsed/Refractory B-Cell Lymphoma Is Effective and Safe in People Living with HIV (PLWH): A Lysa Study from the Descar-T Registry
Authors: Michele Clerico, Axel André, Pierre Sesques, Jean Galtier, Gwenaelle Viard, Sylvain Choquet, Gabriel Brisou, Emilie Corvilain, Laure Ricard, Justine Decroocq, Adrien Cauchet, Amandine Durand, Sylvain Carras, Fabrice Jardin, Magalie Joris, Marie-Thérèse Rubio, Catherine Thieblemont, Alexandra Marquet, Cyrielle de Lacheisserie, Vivien Dupont, David Boutboul, Thierry Lamy, Roberta Di Blasi
Journal: Blood (2024)
Expanding the Role of SH2B3: T Cell Large Granular Lymphocytosis (LGL) and Common Variable Immune Deficiency in the Setting of Biallelic SH2B3 Mutations
Authors: Tiffany Hangse, Shalini Pullarkat, Aaron Boothby, Olga Sala Torra, Lan W. Beppu, Sophie H.R. Storz, Miranda P.G. Zalusky, Danny Miller, Maite de la Morena, Cecilia C.S. Yeung, Sandhya Panch, Eric Allenspach
Journal: Blood (2024)
Improved Post-Transplant Outcomes over Time for Older Patients with Acute Lymphoblastic Leukemia in First Complete Remission. a Study from the EBMT Acute Leukemia Working Party
Authors: Nour Moukalled, Allain-Thibeault Ferhat, Ali Bazarbachi, Didier Blaise, Annoek E. C. Broers, Cristina Castilla-Llorente, Eva-Maria Wagner Drouet, Peter A. Von Dem Borne, Thomas Schroeder, Jakob R. Passweg, Ibrahim Yakoub-Agha, Peter Dreger, Nicolaus Kröger, Renato Fanin, Ludovic Gabellier, Igor Wolfgang Blau, Eolia Brissot, Arnon Nagler, Sebastian Giebel, Mohamad Mohty, Fabio Ciceri
Journal: Blood (2024)
Impact of Frailty in a Prospective Cohort of Patients with MDS Treated with Hypomethylating Agents
Authors: James T England, Liying Zhang, Karen Yee, Michelle Geddes, Nancy Zhu, April Shamy, Heather A Leitch, Mitchell Sabloff, Grace Christou, Brett L. Houston, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas J. Nevill, Amy Trottier, John M. Storring, Mohamed Elemary, Robert Delage, Rena Buckstein
Journal: Blood (2024)
Patient Decision Aid for Extended Duration Thromboprophylaxis for Major Abdominopelvic Cancer Surgery: A Usability Study
Authors: Abdelrahman Noureldin, Victoria Ivankovic, Mary Farnand, Celine Dainhi, Rebecca Auer, Sameer Apte, Lev Bubis, Pamela Hebbard, Justin Rivard, Megan Delisle, Marc Carrier
Journal: Blood (2024)
Autologous CD33CART for Children and Adolescents/Young Adults with Relapsed/Refractory AML: Phase 1/2 Clinical Trial Correlative Biology Analyses Demonstrate Potent <i>in Vitro</i>, <i>In Vivo</i>, and <i>Ex Vivo</i> Anti-Leukemia Activity
Authors: Tommaso Balestra, Camilo Arenas Merizalde, Robert K Chen, John Roach, Brian Bowser, Rachelle Salomon, Anthony Welch, Bonnie Yates, Kristin Schaller, Michael R Verneris, Susanne H.C. Baumeister, Emily M. Hsieh, M. Eric Kohler, Katherine Tarlock, Steven M. Devine, Richard Aplenc, Nirali N. Shah, Terry J Fry, Sarah K. Tasian
Journal: Blood (2024)
Severe COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia or Indolent B-Cell Non-Hodgkin Lymphoma Who Received Pre-Exposure Prophylaxis with Tixagevimab and Cilgavimab in Italy: Preliminary Results of the Observational Study By the Gimema Working Party on Chronic Lymphoproliferative Disorders and By the Fondazione Italiana Linfomi
Authors: Gian Matteo Rigolin, Antonio Urso, Stefano Soddu, Riccardo Moia, Riccardo Dondolin, Attilio Olivieri, Ilaria Scortechini, Annamaria Frustaci, Marina Deodato, Giulia Daghia, Francesca Romana Mauro, Sara Pepe, Marina Motta, Antonella Anastasia, Lydia Scarfo, Emanuela Sant'Antonio, Pellegrino Musto, Annamaria Giordano, Andrea Mengarelli, Martina Tomassi, Sara Martinelli, Caterina Patti, Marika Porrazzo, Alessandro Sanna, Rossella Riccioni, Clara Virginia Vigano', Francesca Paola Paoloni, Alfonso Piciocchi, Paola Fazi, Guido Gini, Andrés José María Ferreri, Paolo Ghia, Antonio Cuneo
Journal: Blood (2024)
Assessment of Classical Hematologists and Hematology-Focused Fellowship Programs at NCI-Designated Cancer Centers: Implications for Addressing Workforce Shortages and Enhancing Mentorship Opportunities
Authors: Lewis T Go, Lucas T Go, Madugodaralalaage DSK Gunaratne, Aneel A Ashrani, Michelle A Elliott, Richard C Godby, C Christopher Hook, Leslie J Padrnos, Rajiv K Pruthi, Candido E Rivera, Rachelle L Rouse, Surbhi Shah, Marwan E Shaikh, Mustaqeem A. Siddiqui, Meera Sridharan, Ewa M Wysokinska, Alexandra P Wolanskyj-Spinner, Ronald S Go, Jithma P Abeykoon
Journal: Blood (2024)
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Retrospective Multicenter Analysis on 285 Procedures Performed between 2000 and 2020
Authors: Corrado Tarella, Simona Sammassimo, Samuele Frassoni, Alida Dominietto, Raffaella Cerretti, Maria Caterina Micò, Rocco Pastano, Martina Pennisi, Chiara Ghiggi, Gottardo De Angelis, Alessandra Algarotti, Patrizia Chiusolo, Enrico Derenzini, Simona Sica, Paolo Corradini, Vincenzo Bagnardi, Emanuele Angelucci, Alessandro Rambaldi, William G Arcese, Anna Dodero, Andrea Bacigalupo
Journal: Blood (2024)
Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Patients with Acute Myeloid Leukemia in First Remission: A Study from the Global Committee and Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Authors: Yishan Ye, Allain Thibeault Ferhat Berland, Myriam Labopin, Jia Chen, Depei Wu, Didier Blaise, Emanuele Angelucci, Edouard Forcade, Xiao-Jun Huang, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Patrice Chevallier, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Yanmin Zhao, Fabio Ciceri, He Huang, Mohamad Mohty, Norbert Claude Gorin
Journal: Blood (2024)
Still You Hesitate to Use Ino?: Inotuzumab Ozogamicin Optimized Post-Transplant Outcomes in R/R Ph-Negative B-ALL
Authors: Ryo Koizumi, Shinsuke Takagi, Aya Nishida, Mika Kuno, Otoya Watanabe, Kyosuke Yamaguchi, Kosei Kageyama, Daisuke Kaji, Yuki Taya, Kazuya Ishiwata, Hisashi Yamamoto, Yuki Asano-Mori, Go Yamamoto, Atsushi Wake, Shuichi Taniguchi, Naoyuki Uchida
Journal: Blood (2024)
Prognostic Significance of Monoclonal Gammopathy in Chronic Lymphocytic Leukemia Under Different Therapeutic Backgrounds
Authors: Yuting Yan, Bolin Yuan, Tingyu Wang, Ying Yu, Weihao Chen, Dandan Shan, Xiong Wenjie, Gang An, Dehui Zou, Lu-Gui Qiu, Qiong Wang, Shuhua Yi
Journal: Blood (2024)